Iimpawu ezidibeneyo ezihlanganiswe neengxaki zesisu
I-arthritis ye-enteropathic yimeko evuzayo echaphazela umlenze kunye namanye amanxube avame ukuvela kwizifo zesibindi sokuvuvukala - isifo sikaCrohn kunye nesifo sezilonda zesilonda. I-arthritis evuthayo echaphazelekayo nezinye izifo ezingenayo i-enteropathic, ezifana nesifo se-celiac kunye nesifo sika-Whipple, aqhelekanga kubandakanywa "kwi-arthritis ye-enteropathic".
I-arthritis ye-enteropathic ibalwa njengenye ye- spondyloarthropathies . Ezinye i-spondyloarthropathies ziquka i- spondylitis e-ankylosing , i- psoriatic arthritis , kunye ne -arthritis esebenzayo . "Ukungena kwiintlobo" kubhekisela nasiphi na isifo esihambelana namathumbu.
Ukuphuhlisa iArthritis ye-Enteropathic
I-arthritis ivela kuma-20 eepesenti yabantu abanezifo zesibindi esivuthayo, kunye nokuxhaphaka okukhulu phakathi kwabo banesifo sikaCrohn xa kuthelekiswa nalabo abane-ulcerative colitis. Kwi-arthritis ye-enteropathic, iimpawu ze-arthritis zingaphambi kwezibonakaliso zesisu sexesha elide.
Ngaphambi kokuba iimpawu zesisu zibe zibonakala, i-arthritis idlalwa njenge-Undifferentiated Spondyloarthritis. Uninzi lwabantu abane-arthritis ye-enteropathic, nangona kunjalo, sele sele ifunyanwe nesinye sezifo ezikhulayo.
Iziphumo zezifundo ezipapashwe kwi-Clinical Rheumatology zicebise ukuba i-IL-23, i-biomarker, iphakamileyo kubantu abanezifo zesibilini, ezinokugula, kwaye ziphezulu kulabo abane-arthritis kunye ne-axial arthritis xa kuthelekiswa nokulawula.
Kufuneka uphando olongezelelweyo, kodwa lunokuba lufumene olubalulekileyo oluya kukhokelela ekujoliswe kuyo.
Iimpawu
I-arthritis ye-enteropathic inokuvela njenge-axial arthritis, i-paripheral arthritis, okanye ixutywe. Njenge-arthritis ye-axial, iimpawu zentlungu emva kunye nokuqina zifana ne-spondylitis e-ankylosing kwaye ingaphambi kwempawu zesisu.
Njengengxaki yesifo se-arthritis, kukho umzekelo we-pauciarticular (ezine iimboniselo ezincinci ezibandakanyekayo) kunye ne-arthritis e-asymmetric (amaxhepha achaphazelekayo awayekho kwicala elifanayo lomzimba). Iingxaki zesisu zingenzeka ngexesha elifanayo ne-arthritis okanye i-arthritis inokwenzeka ngaphambi kokuba izifo zesilonda.
Ukuxilongwa
Ingxoxo evulekileyo nenyanisekileyo kunye nogqirha wakho malunga nazo zonke iimpawu zakho ziza kuqala. Oogqirha ngokuqhelekileyo bavavanya ukukhangela:
- i-anemia
- I- CRP ephakamileyo kunye ne- ESR ibonisa ukuvuvukala
- ukungabikho kweenguqu ezitshintshayo kwi-x-ra yeelpipalal joints
- i-sacroiliac kunye nomjikelezo we-x-ray efana ne-ankylosing spondylitis
Uphononongo olulodwa, olupapashwe kwiZibheno zemiSebenzi, luvandlakanywe kwintsebenzo yeKliniki yokuHlala kunye neRheumatologic. Uphando luye lwabonisa ukuba abantu abane-spondylitis babeneentlobo eziphezulu zezinye izibonakaliso ezongezelelekileyo zamathumbu kwaye bafumana unyango olongezelelweyo nge- TNF blockers kunabantu abanezifo zesisu.
Abo babenempawu eqala ukuphuma kwe-spondylitis ye-enteropathic kwiminyaka elishumi phakathi ko-1980 ukuya ku-1990 kunye no-1991 ukuya ku-2001 babona ukulibaziseka okukhulu ekuxilongweni. Iphucule kakhulu.
Abantu ababenesi sifo sokuqala kwe-spondylitis ye-enteropathic phakathi ko-2002 ukuya ku-2012 banciphise ukulibaziseka ekuxilongweni.
Kubonakala kubonakala ukuba iiklinikhi ezineendlela ezahlukeneyo, ezijolise kwiimpawu ezidibeneyo kunye neempawu zesisu, zichanekileyo kule ngxaki yokuxilonga.
Unyango
I-arthritis ye-enteropathic iphathwa ngokufana nezinye i-spondyloarthropathies zeempawu ezihlanganyelweyo. Ingxaki kukuba zonke iimeko kufuneka ziqwalaselwe-isifo se-arthritis kunye nesifo sesilonda-kodwa njengoko ii-NSAID zingaphatha kakuhle i-arthritis, iziyobisi zingenza izifo zesisu zibe zibi nakakhulu.
I-TNF inhibitors, ezibandakanya i- Remicade (infliximab), i- Humira (adalimumab) ne- Cimzia (certolizumab pegol) sele isetyenziswe ngempumelelo ekuphatheni izifo zesibindi.
Ziyakwazi ukuphumelela kwi-arthritis evuthayo.
ILizwi
Ngokutsho kwe-Spondylitis Association of America, ikhosi kunye nobuqili be-arthritis ye-enteropathic iyahluka ukusuka kumntu ukuya komntu. Nangona izifo zomlilo kwi-arthritis ye-enteropathic zivame ukuzincipha kwaye zithintele emva kweiveki ezintandathu, ukuphindaphinda kuqhelekile. Kwaye, inxalenye ye-arthritis ye-arthritis ye-enteropathic ingaba yinto engapheliyo kwaye ingadibana nokutshatyalaliswa. Akukho nonyango eyaziwayo ye-arthritis ye-enteropathic, kodwa imichiza inceda ukulawula zombini isilonda kunye nesifo se-arthritic se-arthritis ye-enteropathic.
> Imithombo:
> I-intopathic Spondyloarthritis. I-Primer kwi-Rheumatic Diseases. Ishumi elinesithathu. Ipapashwe ngu-Arthritis Foundation.
> Gheita, TA. Ukubandakanyeka kwe-IL-23 kwizigulane ze-arthritis ezihamba ngesifo esilumkileyo: iziphumo zokuqala. Rheumatology Clinic. 2014 ngoMeyi; 33 (5): 713-7.
> Conigliaro P., et al. Impembelelo yeendlela ezahlukeneyo kwizigulane ze-spopyloarthritis ezise-enteropathic. I ziPhulo zeMoto. 2016 Feb; 15 (2): 184-90.
> Ubume be-Arthritis / iArthritis edibeneyo ye-Enteropathic ehambelana nezifo ezibangelwa zizifo. I-Spondylitis Association of America.